Full Text View
Tabular View
Study Results
Related Studies
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients
This study has been completed.
Study NCT00255177   Information provided by VGX Pharmaceuticals, LLC

First Received on November 15, 2005.   Last Updated on October 30, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial